Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database

Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database

<b>Background:</b> Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used to treat obesity and diabetes but are linked to a variety of gastrointestinal (GI) adverse events (AEs). Real-world data on GLP-1 RA-related GI AEs and outcomes are limited. This study assessed GI...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel Prince Osei, Edwin Akomaning, Teodora Francesca Florut, Mohit Sodhi, Brian E. Lacy, Wafa A. Aldhaleei, Akshaya Srikanth Bhagavathula
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Diagnostics
Subjects:
glucagon-like peptide-1 receptor
diabetes mellitus
adverse drug reaction reporting systems
gastrointestinal diseases
pharmacovigilance
weight loss agents
Online Access:https://www.mdpi.com/2075-4418/14/24/2829
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items